# Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD

> **NCT04421287** · PHASE4 · UNKNOWN · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Stable Coronary Heart Disease

## Interventions

- **DRUG:** Zhenyuan capsule

## Key facts

- **NCT ID:** NCT04421287
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04421287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04421287, "Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04421287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*